AXON

Axon

Stock NASDAQ – Stock Market Prices, News & Analysis

Axon Enterprise Inc produces non-lethal for law enforcement, including body cameras and Tasers.

$ 413.07
0.06 %

Axon

$ 413.07
0.06 %
AXON

Axon Enterprise Inc produces non-lethal for law enforcement, including body cameras and Tasers.

Price history of Axon
Price history of Axon

Performance & Momentum

6 Months 40.31 %
1 Year 21.54 %
3 Years 86.74 %
5 Years 196.81 %

Strategic Analysis

Axon • 2026

Axon Enterprise Inc positions itself as a leader in non-lethal technology solutions for law enforcement, combining hardware (body cameras, Tasers) and digital evidence management platforms. Its model integrates a comprehensive offering that promotes customer loyalty among institutional clients in a high-stakes niche segment.

Strengths
  • Dominant position in a rapidly growing specialized market related to public safety issues
  • Proprietary technology paired with a complete software platform facilitating recurring revenue
  • Strong long-term performance history demonstrating innovation and expansion capability
Weaknesses
  • Sensitivity to regulatory changes and political climate affecting law enforcement demand
  • Recent volatile performance with short-term correction, reflecting exposure to public trust cycles
Momentum

Despite a setback in the medium term, momentum remains high, indicating sustained investor interest and a favorable underlying dynamic for the medium to long term, particularly due to the robustness of the model and ongoing innovation.

Analysis performed 1 month ago

Recent News

Axon

illustration
Axon Plummets 30% Amid AI Concerns, Disappointing Margins
2 months ago

Axon Enterprise (NASDAQ: AXON) shares have plunged more than 30% in just over a week. This sharp decline is mainly due to investor worries about the disruptive impact of artificial intelligence on the software sector, coupled with weaker-than-expected margins in Q4 2025. Additionally, political debates around the Department of Homeland Security's budget and sensitive events involving the use of Axon's products in the U.S. have weighed on sentiment. With significant institutional ownership, the stock may face continued short-term pressure.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone